Fresh analysis suggests that individuals who stop using popular slimming jabs like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle regimens.
Published data in a major health publication shows that while overweight individuals often shed substantial amounts of their body weight while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Users using such drugs must be cognizant of the potential of quick weight regain when the medication ends," cautioned researcher Dr. Susan Jebb.
Such speed of regain suggests a reversion to original mass in about 18 months.
Comparing Treatments
The study, which examined dozens of trials involving over 9,000 of patients, compared the effects of these new drugs with conventional dieting.
Scientists emphasize that individuals who lose weight through diet and exercise generally have a slower weight regain—approximately 100 grams monthly—after stopping.
Understanding the Quick Rebound
Doctors suggest the way of the jabs is key to understanding the accelerated rebound.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement means hunger is no longer kept in check, making binge eating far more likely."
A Lifelong Issue?
The NHS recommend the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Professionals argue that, considering the significant potential of relapse, the treatment should be considered long-term.
This view is echoed by drug manufacturers, who state that the results "emphasize the chronic nature of excess weight," akin to managing conditions like high blood pressure.
User Testimonies
Users who have come off the medication describe a powerful resurgence of cravings.
"It was like a trigger activating and I was suddenly ravenous," recalled one woman.
This challenge is worsened if users have not developed sustainable dietary or behavioural modifications during therapy.
Growing Adoption
Survey data indicate that millions of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is greater among females than males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while the jabs are potent agents for weight loss, they are not a standalone fix and lasting health benefits hinges on combined lifestyle support.
